共 46 条
PIK3CA and ESR1 mutations detected in circulating tumor DNA (ctDNA) are predictive factors for late-line hormone-based therapies in ER+/HER2-metastatic breast cancer (MBC)
被引:0
|作者:
Chen, Tom Wei-Wu
[1
]
Dai, Ming-Shen
[2
]
Chang, Dwang-Ying
[1
]
Lin, Ching-Hung
[3
]
Chen, I-Chun
[3
]
Wang, Ming-Yang
[1
]
Huang, Ling-Yi
[4
]
Hsu, An
[4
]
Zhuo, De-Wei
[4
]
Tan, Kien Thiam
[4
]
Lu, Yen-Jung
[4
]
Chang, Shu-Han
[1
]
Cheng, Ann-Lii
[3
]
Lu, Yen-Shen
[1
]
机构:
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Triserv Gen Hosp, Taipei, Taiwan
[3] Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan
[4] ACT Genom Co Ltd, Taipei, Taiwan
关键词:
D O I:
10.1158/1538-7445.SABCS19-P5-01-21
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
P5-01-21
引用
收藏
页数:3
相关论文
相似文献